Menu
2023 Session

Budget Amendments - SB800 (Floor Approved)

View Budget Item
View Budget Item amendments

Sickle Cell Disease Support

Item 308 #4s

Item 308 #4s

First Year - FY2023 Second Year - FY2024
Health and Human Resources
Department of Medical Assistance Services FY2023 $0 FY2024 $50,000 GF
FY2023 $0 FY2024 $50,000 NGF

Language
Page 385, line 32, strike "$289,288,829" and insert "$289,388,829".

Page 393, after line 33, insert:

"II. The Department of Medical Assistance Services (DMAS) shall conduct an annual review of all medications, forms of treatment for sickle cell disease, and services for enrollees with a diagnosis of sickle cell disease, that are eligible for coverage under the Medicaid program. The purpose of this annual review is to determine if the available covered medications, treatments, and services are adequate to meet the needs for enrollees with a diagnosis of sickle cell disease, and whether DMAS should seek to add additional medications, treatments, or services. DMAS shall solicit and consider input from the public, specifically persons or groups with knowledge and experience in sickle cell disease treatment."



Explanation

(This amendment provides that the Department of Medical Assistance Services shall conduct an annual review of all medications, forms of treatment for sickle cell disease, and services for enrollees with a diagnosis of sickle cell disease, that are eligible for coverage under the Medicaid program.)